225 related articles for article (PubMed ID: 25142630)
1. Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.
Tirumani SH; Deaver P; Shinagare AB; Tirumani H; Hornick JL; George S; Ramaiya NH
J Gynecol Oncol; 2014 Oct; 25(4):306-12. PubMed ID: 25142630
[TBL] [Abstract][Full Text] [Related]
2. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
3. Distant Metastases in Uterine Leiomyosarcomas: The Wide Variety of Body Sites and Time Intervals to Metastatic Relapse.
Bartosch C; Afonso M; Pires-Luís AS; Galaghar A; Guimarães M; Antunes L; Lopes JM
Int J Gynecol Pathol; 2017 Jan; 36(1):31-41. PubMed ID: 27015437
[TBL] [Abstract][Full Text] [Related]
4. Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.
Lamm W; Natter C; Schur S; Köstler WJ; Reinthaller A; Krainer M; Grimm C; Horvath R; Amann G; Funovics P; Brodowicz T; Polterauer S
BMC Cancer; 2014 Dec; 14():981. PubMed ID: 25523155
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.
Loizzi V; Cormio G; Nestola D; Falagario M; Surgo A; Camporeale A; Putignano G; Selvaggi L
Oncology; 2011; 81(2):91-7. PubMed ID: 21968290
[TBL] [Abstract][Full Text] [Related]
6. [Metastatic lung tumor from uterine leiomyosarcoma].
Nishida T; Shoji S; Itoh T; Minami H; Akizuki K; Ozuno I; Kageyama H; Ozaki I; Yamamoto K; Yamamoto A; Nishiyama N
Kyobu Geka; 2006 Dec; 59(13):1191-6. PubMed ID: 17163213
[TBL] [Abstract][Full Text] [Related]
7. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
[TBL] [Abstract][Full Text] [Related]
8. Predictors of survival and recurrence in primary leiomyosarcoma.
Gladdy RA; Qin LX; Moraco N; Agaram NP; Brennan MF; Singer S
Ann Surg Oncol; 2013 Jun; 20(6):1851-7. PubMed ID: 23354568
[TBL] [Abstract][Full Text] [Related]
9. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.
Iasonos A; Keung EZ; Zivanovic O; Mancari R; Peiretti M; Nucci M; George S; Colombo N; Carinelli S; Hensley ML; Raut CP
Cancer; 2013 May; 119(10):1816-22. PubMed ID: 23456762
[TBL] [Abstract][Full Text] [Related]
10. Uterine leiomyosarcoma: an updated series.
Rauh-Hain JA; Oduyebo T; Diver EJ; Guseh SH; George S; Muto MG; del Carmen MG
Int J Gynecol Cancer; 2013 Jul; 23(6):1036-43. PubMed ID: 23714705
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of 105 cases with uterine sarcoma.
Yoney A; Eren B; Eskici S; Salman A; Unsal M
Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.
Rauh-Hain JA; Hinchcliff EM; Oduyebo T; Worley MJ; Andrade CA; Schorge JO; George S; Muto MG; del Carmen MG
Int J Gynecol Cancer; 2014 Oct; 24(8):1434-40. PubMed ID: 25248114
[TBL] [Abstract][Full Text] [Related]
13. Uterine leiomyosarcoma: analysis of treatment failures and survival.
Gadducci A; Landoni F; Sartori E; Zola P; Maggino T; Lissoni A; Bazzurini L; Arisio R; Romagnolo C; Cristofani R
Gynecol Oncol; 1996 Jul; 62(1):25-32. PubMed ID: 8690287
[TBL] [Abstract][Full Text] [Related]
14. Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases.
Hsieh CH; Lin H; Huang CC; Huang EY; Chang SY; ChangChien CC
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):74-81. PubMed ID: 12580845
[TBL] [Abstract][Full Text] [Related]
15. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
[TBL] [Abstract][Full Text] [Related]
17. Metastasis in dedifferentiated liposarcoma: Predictors and outcome in 148 patients.
Tirumani SH; Tirumani H; Jagannathan JP; Shinagare AB; Hornick JL; Ramaiya NH; Wagner AJ
Eur J Surg Oncol; 2015 Jul; 41(7):899-904. PubMed ID: 25659772
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of systemic therapy for advanced uterine leiomyosarcoma: A systematic review, meta-analysis, and meta-regression analysis.
Ijaz I; Shahzad MN; Hosseinifard H; Liu S; Sefidan MO; Kahloon LE; Imani S; Hua Z; Zhang YQ
Cancer Med; 2023 Jul; 12(13):13894-13911. PubMed ID: 37081717
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas.
Ng EH; Pollock RE; Romsdahl MM
Cancer; 1992 Mar; 69(6):1334-41. PubMed ID: 1540870
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]